Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:00:19.059Z.
Calculation as of: 2026-10-06T14:00:19.059Z.
Quote observation: 2026-10-06T13:59:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a29a88061d86e64317c53e71c63756e58f7ffa0b55551e6148327154cc786467
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Actuate Therapeutics Inc
Market Cap
$19.26M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.02M
Operating Cash Flow Yield
N/A
TTM Avg
7.24%
3Y Avg
5.87%
5Y Avg
5.87%
Market Cap
$18.87M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.19M
Operating Cash Flow Yield
N/A
TTM Avg
2.46%
3Y Avg
5.67%
5Y Avg
4.13%
Market Cap
$16.64M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.00M
Operating Cash Flow Yield
14.91%
TTM Avg
7.71%
3Y Avg
27.75%
5Y Avg
27.75%
Market Cap
$16.49M
Operating Cash Flow Yield
N/A
TTM Avg
4.27%
3Y Avg
3.48%
5Y Avg
4.26%
Market Cap
$15.75M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $19.26M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $19.02M | N/A | 7.24% | 5.87% | 5.87% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.87M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $17.19M | N/A | 2.46% | 5.67% | 4.13% |
| Lipocine Inc. (LPCN)vs › | $17.07M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 14.91% | 7.71% | 27.75% | 27.75% |
| BioCardia, Inc. (BCDA)vs › | $16.49M | N/A | 4.27% | 3.48% | 4.26% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.80M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
